Ku saabsan Dhakhtarka
Dr. Shigenobu Suzuki wuxuu ka mid yahay khabiirka ugu sarreeya ee kansarka indhaha ee Tokyo, Japan.
Dr. Shigenobu Suzuki wuxuu xiriir la leeyahay Isbitaalka Qaranka ee Kansarka, Japan.
The Department of Ocular Oncology is one of the rare groups specializing in ocular tumors, especially intraocular tumors. Recently, more than 70% of patients nationwide with retinoblastoma, which is the most frequent intraocular malignancy in childhood, and more than 50% of patients with choroidal melanoma, which is the most frequent primary intraocular malignancy in adults, have been referred to our department. We also treat ocular adnexal tumors. More than 350 operations have been done annually.
Waxaan ka qaybqaadaneynaa tijaabooyinka bukaan-socodka anagoo qiyaasayna dhacdooyinka xun ee indhaha ee daaweynta kiimikaad ee habaysan. Daawaynta molecular ee dhawaa waxay mararka qaar keentaa barar macular, go'aan indho-daraan ah, uveitis, cudurka dusha indhaha, iyo wixii la mid ah, waxaanu qiimaynaa oo aanu daawaynaa dhacdooyinkan xun si aanu ugu biirinno tijaabooyin caafimaad.
Hospital
takhasus
- Oncology indhaha
Nidaamyada la fuliyay
- Oncology indhaha
- Retinoblastoma
- Cudur barar
- Choroidal melanoma
